|
|
sommaire
Retour au texte.
2. Anderson B., Connor J.P., Andrews J.I., Davs C.S., Buller R.E., Sorosky J.I,Benda J.A. Obesity and prognosis in endometrial cancer . Am. J. Obstet.
Gynecol., 1996, 174, 1171-1179.
3. Anderson B., Seipell J., Terning K., Bjorntorp P. Influence of menopause ondietary treatment of obesity. J. Inter. Med., 1990, 227, 173-181.
4. Austin H., Austin J.M., Partridge E.E., Hatch K.D., Shingleton H.M.Endometrial cancer, obesity and body fat distribution. Cancer Research, 1991,
51, 568-572.
5. Azmi A., Nabulsi M.B., Aaron R., Falson M.D., Association of hormonereplacement therapy with various cardiovascular risk factors in postmenopausal
women. N. Engl. J. Med., 1993, 328, 1069-1075.
6. Barbone F., Austin H., Partridge A.E. Diet and endometrial cancer: acase-control study. Am. J. Epidemiol., 1993, 137, 393-403.
7. Barret-Connor E., Laasko M. Ischemic heart disease risk in post menopausalwomen: effects of estrogen use on glucose and insuline levels.
Arteriosclerosis, 1990, 10, 531-534.
8. Barret-Connor E., Wingard D., Criqui D. Postmenopausal estrogen use in the1980's Rancho Bernardo California revisited. JAMA, 1989, 261, 2095-2100.
9. Basdevant A., Hautecouverture M. Effets des estrogènes sur lemétabolisme des lipides et des glucides. Rev. Prat., 1979, 29,
1769-1781.
10. Beattie P.G., Rings T.R., Hunter M.F., Lake Y. Risk factors for woundinfection following cæsarean section. Aust. N.Z. J. Obstet.
Gynæcol., 1994, 34, 398-402.
11. Berlan M., Lafon Tan M. Biochimie et régulation métaboliquede tissu adipeux. Ed. Techniques, EMC Gla 4, Paris, 1991, 10506 B10.
12. Botwood N., Hamilton-Fairley D., Kiddy D., Robinson S., Franks S. Sexhormone binding globulin and female reproductive function. J. Steroid. Biochem.
Molec. Biol., 1995, 53, 529-531.
13. Bouchard C. Génétique des obésités. Ed.Techniques, EMC Gla 4, Paris, 1991, 10506 C10, 4p.
14. Breen T.W., Ransil B.J., Groves P.A., Oriol N.E. Factors associated withback pain after child birth. Anesthesiology, 1994, 81, 29-34.
15. Brettes J.P. La grossesse chez les obèses. Vokaer R., Traitéd'obstétrique (tome 2); Masson éd. , Paris, 1985, p. 233-243.
16. Bringer J., Bouhaddioni L., Thalabard J.C. Relationship between body massindex and pulsatile luteinizing-hormone (LH) secretion estradiol and androgens
in anovulatory women. The Endocrine Society, 70th annual meeting, 1988, abst
834.
17. Bruckert E., Turpin G. Estrogènes et progestatifs chez la femmeménopausée. Influence sur les paramètres lipidiques et sur
le risque cardio-vasculaire. Reprod. Hum. Horm., 1993, 6, 243-249.
18. Brüning P.F., Bonfrer J.M.G., Van Noord P.A.H., Hart A.A.M., DeJong-Bakker MM., Nooijen W.K. Insulin resistance and breast cancer risk. Int.
J. Cancer, 1991, 52,511-516.
19. Bulbrook R.D. Geographic variation in endocrine function and its relation
20. Byron J.W., Fujiyoschi C.A., Miyazawa K. Evaluation of the direct trocarinsertion technique at laparoscopy. Obstet. Gynecol., 1989, 74, 423-425.
21. Chao C.K.S., Grigsby P.W., Perez C.A., Camel H.M., Kao M.S, Galakatos A.E.,Boyle W.A. Brachytherapy-related complications for medically inoperable stad I
endometrial carcinome. Int. J. Radiation Oncology Biol. Phys. 1995, 31,
37-42.
22. Charlot A., Goodfroid I. Les complications de la grossesse liéesà l'obésité maternelle. Jobgyn, 1996, 4, 16-20.
23. Childers J.M., Brzechffa P.R., Hatch K.D., Surwit E.A. Laparoscopicallyassisted surgical staging (Lass) of endometrial cancer. Gynecol. Oncol., 1993,
51, 33-38.
24. Childers J.M., Hatch K.D., Tran A.N., Surwit E.A. Laparoscopic para-aorticlymphadenectomy in gynecologic malignancies. Obstet. Gynecol., 1993, 82,
741-747.
25. Clark A.M., Ledger travail., Galletly C., Tomlinson L., Blaney F., Wang X.,Norman R.J., Weight loss results in significant improvement in pregnancy and
ovulation rates in anovulatory obese women. Hum. Reprod., 1995, 10,
2705-2712.
26. Cleland W.H., Mendelson C.R., Simpson E.R. Aromatase activity of membranefractions of human adipose tissue stroma cells and adipocytes. Endocrinology,
1983, 113, 2155-2158.
27. Cogswell M.E., Serdula M.K., Hungerford D.W., Yip R. Gestational weightgain among average-weight and overweight women. What is excessive? Am. J.
Obstet. Gynecol., 1995, 172, 705-712.
28. Conover C.A., Lee P.D.K., Kanaley J.A., Clarkson J.T., Jensen M.D. Insulinregulation of IGF binding protein 1 in obese and non-obese humans. J. Clin.
Endocrinol. Metab., 1992, 74, 1355-1360.
29. Corocleanu M. Hypothesis for endometrial carcinoma carcinogenesis. Clin.Exp. Obst. Gyn. 1993, 4, 254-258
30. Daniell H.W., Tam E., Filice A. Larger axillary metastases in obese womenand smokers with breast cancer and influence by host factors on early tumor
behavior. Breast Cancer Research and Treatment, 1993, 25, 193-201.
31. De Waard F. Endocrine aspects of cancer, an epidemiological approach. J.Steroid Biochem. Mol. Biol., 1991, 40, 15-19.
32. Deslypere J.P. Obesity and cancer. Metabolism 1995, 9, 24-27.
33. Edwards L.E. Pregnancy complications and birth outcomes in obese andnormal-weight women: affects of gestational weight change. Obstet. Gynecol.,
1996, 87, 389-394.
34. Eklad U., Grenman S. Maternal weight gain during pregnancy and pregnancyoutcome. Int. J. Gynæcol. Obstet., 1992, 39, 277-283.
35. Fabre J., François G. Anesthésie-Réanimation del'obèse. Encycl. Méd. Chir., Paris, 1984,
Anesthésie-Réanimation, 36650 A10-3.
36. Faure E., Mo R., Thisted R. Incidence of postdural puncture headache inmorbidly obese parturients. Regional Anesthesia, 1994, 19, 361-363.
37. Féher T., Bodrogi L., Vallent K., Ribai Z. Role of human adiposetissue in the production and metabolism of steroid hormone. Endocrinology,
1982, 80, 173-780.
38. Foley K., Lee R.B. Surgical complications of obese patient with endometrialcarcinoma. Gynecol. Oncol., 1990, 39, 171-174.
39. Folson A.R., Kaye S.A., Potter J.D., Prineas R.J. Association of incidentcarcinoma of the endometrium with body weight, and fat distribution in older
women: early finding of the Iowa womens health study. Cancer Res., 1989, 49,
6828-6831.
40. François G., Gouin F., Sicard-Desmuelle M.P. Anesthésiesuivant la pathologie associée. In François G., Lara M., du
Carlar J., d'Athis F., Gouin F., Poisvert M., Précis
d'Anesthésie, Masson, 1985, Paris, 335-365.
41. Franks S., Hamilton-Fairley D., Le rôle du poids et des anomaliesmétaboliques dans l'induction de l'ovulation. Contracept. Fertil. Sex.,
1994, 22, 178-179.
42. Galtier-Dereure F., Boulot P. Complications obstéricales du surpoidsmaternel. Contracept. Fertil. Sex., 1994, 22, 113-116.
43. Galtier-Dereure F., Montpeyroux F., Boulot P., Bringer J., Jaffiol C.Weight excess before pregnancy: complications and cost. Int. J. Obes. Relat.
Metab. Disord, 1995, 19 , 443-448.
44. Garbaciak J.A., Richter M.D., Miller S., Barton J.J. Maternal weight andpregnancy complications. Am. J. Obstet. Gynecol., 1985, 152, 238.
45. Garner P.R. The Impact of obesity on reproductive function. Seminars inReproductive Endocrinology, 1990, 8, 32-43.
46. Giudice L.C. Insulin like growth factors and ovarian folliculardevelopment. Endocrine Rev., 1992, 13, 641-669.
47. Glosten B. Obesity and obstetric anesthesia. Seminars in Anesthesia, 1992,11, 43-50.
48. Goldzieher J.W., Green J.A. The polycystic ovary: clinical and histologicalfeatures. J. Clin. Endocrinol. Metab., 1962, 22, 325-338.
49. Grady D., Rubin S.M., Petitti D.B., Fox C.S. Hormone therapy to preventdisease and prolong life in postmenopausal women. Ann. Int. Med., 1992, 117,
1016-1037.
50. Green B.B., Weiss N.S., Danling J.R. Risk of ovulatory infertility inrelation to body weight. Fertil Steril., 1988, 50, 721-726.
51. Gross P., Werhya G., Seng. G. Obésité:épidémiologie et risques de l'obésité. Rev. Prat.,
1989, 39, 2355-2360.
52. Haarbo J., Marslew U., Gotfredsen A., Christiansen C. Postmenopausalhormone replacement therapy prevents central distribution of body fat after
menopause. Metabolism, 1991, 40, 1323-1326.
53. Hartz A.J., Barboriak P.N., Wong A. et coll. The association of obesitywith infertility and related menstrual abnormalities in women. Int. J. Obes.,
1979, 3, 57-60.
54. Haffner S.M., Bauer R.L. The association of obesity and glucose and insulinconcentration with bone density in premenopausal and post menopausal women.
Metabolism, 1993, 42, 735-738.
55. Hassager G., Christiansen C. Estrogen/ gestagen therapy changes soft tissuebody composition in post-menopausal women. Metabolism, 1989, 38, 662-665.
56. Henderson B.E., Paganini-Hill A., Ross R.K. Decreased mortality in users ofestrogen replacement therapy. Ann. Int. Med., 1991, 151, 75-78.
57. Hood D.D., Dewan D.M. Anesthesic and obstetric outcome in morbidly obeseparturients. Anesthesiology, 1993, 79, 1210-1218.
58. Howe G., Westhoff C., Vessey M., Yeates D. Effects of age, cigarettesmoking, and other factors on fertility: findings in a large prospective study.
Br. Med. J., 1985, 290, 1697-1700.
59. Hurd W.H., Bude R.O., De Lancey J.O., Gauvin J.M., Aisen A.M. Abdominalwall characterization with magnetic resonance imaging and computed tomography.
The effect of obesity on the laparoscopic approach. J. Reprod. Med., 1991,
473-476.
60. Inoue M., Okayama A., Fujita M., Enomoto T., Tanizawa 0., Ueshima H. A case- control study of risk factors for uterine endometrial cancer in Japan. Jpn.
J. Cancer Res. 1994; 85; 346-350.
61. Isaacs J.D., Magann E.F., Martin R.W., Chauhan S.P., Morrison J.C.Obstetric challenges of massive obesity complicating pregnancy. J.
Périnatol., 1994, 14, 10-14.
62. Johnson S.R., Kolberg B.H., Varner M.W., Railsback L.D. Maternal obesityand pregnancy. Surg. Gynecol. Obstet., 1987, 164, 431.
63. Kadar N., Homesley H., Malfetano J. New perspectives on the indications forpelvic and para-aortic lymphadenectomy in the management of endometrial
carcinoma and their relevance to laparoscopic staging. Gynæco. Endosc.,
1995, 4, 109-118.
64. Kadar N., Pelosi M.A. Laparoscopically assisted hysterectomy in womenweighing 200 lb or more. Gynæco. Endosc., 1994, 3, 159-162.
65. Kaleko M., Rutter W.J., Miller A.D. Over expression of the human IGF1receptor promotes ligand-dependent neoplastic tranformation. Mo. Cell Biol.,
1990, 10, 464-473.
66. Kaye S.A., Folsom A.R., Prineas R.J., Potter J.D., Gapstur S.M. Theassociation of body fat distribution with lifestyle and reproductive factors in
a population study of postmenopausal women. Int. J. Obes., 1990, 14, 583-591.
67. Kimura M. Obesity as prognostic factors in breast cancer. Diabetes Research
68. Kneale B.L.G, Giles G.G. Endometrial cancer: Trends in incidence andsurvival: a preventable disease. Aust. N. Z. J. Obstet. Gynecol. 1993, 33,
1-7.
69. Kodama M., Kodama T., Miura S., Yoshida M. Nutrition and breast cancer riskin Japan. Anticancer Res., 1991, 11, 745-754.
70. Laffargue F. Faire et ne pas faire dans la prise en charge des cancers del'endomètre. Jobgyn, 1995, 3, 274-278.
71. Lapidus L., Helgesson O., Merck C., Bjorntorp P. Adipose tissuedistribution and female carcinoma. A 12 years follow up of participants in the
population study of women in Gothenburg, Sweden. Int. J. Obes., 1988, 12,
361-368.
72. Le Thai N., Lefebvre G., Stella V., Vauthier D., Sfoggia D., Goulon V.,Darbois Y. Grossesse et obésité. À propos d'une
étude cas-témoin de 140 cas. J. Gynecol. Obstet. Biol. Reprod.,
1992, 21, 563-567.
73. Levi F., La Vecchia C., Negri E., Parazzini F., Franceschi S. Body mass atdifferent ages and subsequent endometrial cancer risk. Int. J. Cancer 1992, 50,
567-571.
74. Lindberg U.B., Crona N., Silfverstolpe G. Regional adipose tissuemetabolism in post menopausal women after treatment with exogenous sex
steroids. Horm. Met. Res., 1990, 22, 345-354.
75. London S.J., Colditz G.A., Stampfer M.J. Propective study of relativeweight, height and risk of breast cancer. J. Am. Med. Assoc., 1989, 65,
311-320.
76. Lorcy Y., Le Guerrier A.M., Allannic H. Contraception chez la femmeà haut risque vasculaire (diabétique exceptée). Concours
Médical, 1984, 106, 835-845.
77. Lorcy Y. Obesité et maigreurs: leurs conséquences sur lafonction ovarienne et la reproduction. Reprod. Hum. Horm., 1993, 6, 315-320.
78. Luotola H., Pyörälä T., Coikkamen M. Effects of naturaloestrogen/progesteron substitution therapy on carbohydrate and lipid metabolism
in postmenopausal women. Maturitas, 1986, 8,245-253.
79. McGuire W.L., Jackson J.G., Figueroa J.A., Shimasaki S., Powell D.R., YeeD. Regulation of IGFBP expression by breast cancer cells, use of IGFBP1 as an
inhibitor of IGF action. J. Natl. Cancer Inst., 1992, 84, 1336-1341.
80. Mehta R.R., Hart G., Dasgupta T.K. Steroid receptors in breast cancerpatients. Influence of obesity and age at diagnosis. Anticancer Research, 1992,
12, 1311-1314.
81. Montella M., Maffeo A., De Marco M.R., Gallo M.S., Romeo F., Ventura R.Epidemiology and survival of endometrial cancer Eur. J. Gynaec. Oncol. 1995; 4;
310-318.
82. Naeye R.L. Maternal body weight pregnancy outcome. Am. J. Clin. Nutr.,1990, 52,273-279.
83. Panel P., De Meeus J., Yanoulopoulos B., Deshayes M., Magnin G.Accouchement du gros enfant. Conduite à tenir et résultats
à propos de 198 dossiers. J. Gynécol Obstet. Biol. Reprod., 1991,
79, 1210-1218.
84. Pascali R., Antenucci D., Caimirri F., Venturoli S., Paradisi R., FabbriR., Balestra V., Melchionda N., Barbara L. Clinical and hormonal
characteristics of obese amenorrheic hyperandrogenic women before and after
weight loss. J. Clin. Endocrinol. Metab., 1989, 68, 173-179.
85. Perlow J.H., Morgan M.A. Massive maternal obesity and perioperativecæsarean morbidity. Am. J. Obstet. Gynecol., 1994, 170, 560-565.
86. Perlow J.H., Morgan M.A., Montgomery D., Towers C.V., Porto M. Perinataloutcome inpregnancy complicated by massive obesity. Am. J. Obstet. Gynecol.,
1992, 167, 560-565.
87. Plymate S.R., Matej L.A., Jones R.E., Friedl K.E. Inhibition of sex hormonbinding globulin production in human hepatoma (Hep G2) cell line by insulin and
prolactin. J. Clin. Endocr. Metab., 1988, 67, 460-464.
88. Potischman N., Swanson C.A., Brinton L.A., Mc Adams M., Barrett R.J.,Berman M.L., Mortel R., Twiggs L.B., Wilbanks G.D., Hoover R.N. Dietary
associations in a case-control study of endometrial cancer. Cancer causes and
control, 1993, 4, 239-250.
89. Querleu D. Voies d'abord. Techniques chirurgicales en Gynécologie,Masson éd., Paris, 1995, 14-44.
90. Rannevik G., Jeppsson S. Modifications périménopausiques destaux sériques de gonadotrophines, d'estrogènes,
d'androgènes et de protéine de liaison des hormones sexuelles
(SBP). Reprod. Hum. Horm., 1992, 5, 435-443.
91. Rebuffe Scrive M. Steroid hormones and distribution of adipose tissue. ActaMed. Scand., 1988, Suppl., 723-743.
92. Reich H., Levie M., McGlynn F., Sekel L. Establishment of pneumoperitoneumthrough the left ninth intercostal space. Gynæco. Endosc., 1995, 4,
141-143.
93. Reid I.R., Ames R., Evans C., Sharpe S., Gamble G., France J.T., LimT.M.T., Cyndy T.F. Determinants of total body and regional bone mineral density
in normal postmenopausal women. A key role for fat mass. J. Clin. Endocrinol.
Metab., 1992, 75, 45-51.
94. Reid R.L., Van Vugt D.A. Weight related changes in reproduction function.Fertil. Steril., 1987, 48, 905-913.
95. Rich-Edwards J.W., Manson J.E., Goldman M.B., Stamper M.J., Colditz G.A.,Hunter D.J., Speizer F.E., Willett W.C. Body mass index at age 18 years and the
risk of subsequent ovulatory infertility (Abstract) Am. J. Epidemiol., 1992, 5,
247-250.
96. Robinson S., Kiddy D., Gelding S.V., Willis D., Niththyanan Than R., BushA., Johnston D.G., Franks S. The relationship of insulin sensitivity to
menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin.
Endocr., 1993, 39, 351-355.
97. Rocke D.A., Murray W.B., Rout C.C., Gouws E. Relative risk analysis offactors associated with difficult intubation in obstetric anesthesia.
Anesthesiology, 1992, 77, 67-73.
98. Rogers J., Mitchell G.W. The relation of obesity to menstrual disturbances.N. Engl. J. Med., 1952, 247, 53-55.
99. Rozenberg J.C., Guzman E.R., Vintzileos A.M., Knuppel R.A. Transluminalplacement of the vaginal probe in obese pregnant women. Obstet. Gynecol, 1995,
85, 132-134.
100. Sala X., Fernandez C., Fita G., Soley R., Deulofeu P., De Jose Maria B.,Davi B., Nalda M.A. Bradyarythmias during gynecologic laparoscopy. Prog.
Obstet. Gynecol., 1995, 38, 320-326.
101. Salvat J., Guilbert M., Fellahi L., Elfekhi J. La coelioscopie ouverte:bilan de sa pratique simplifiée et systématique à propos
de 1358 cas en série continue. Contracept. Fertil. Sex., 1989, 17,
355-358.
102. Samojlik E., Kirschner M.A., Silber D., Schneider G., Erter N.H. Elevatedproduction and metabolic clearance rates of androgens in morbidly obese women.
J. Clin. Endocrinol. Metab., 1984, 59, 949-954.
103. Sellers T.A., Kushi L.H., Potter J.D., Kaye S.A., Nelson C.L., Mc GovernP.G., Folsom A.R. Effect of family history, body fat distribution and
reproductive factors on the risk of postmenopausal breast cancer. N. Engl. J.
Med., 1992, 326, 1323-1329.
104. Shapira D.V., Kumar N.B., Luman G.H., Cavanagh D., Roberts W.S, La PollaJ. Upper body fat distribution and endometrial cancer risk. JAMA, 1991, 266,
1808-1811.
105. Shu X.O., Brinton L.A., Zheng W., Swanson C.A., Hatch M.C., Gao Y.T.,Fraumeni J.F. Relation of obesity and body fat distribution to endometrial
cancer in Shangai, China. Cancer Res., 1992; 52; 3865-3870.
106. Singh A., Hamilton-Fairley D., Koistinen R., Seppala M., James V.H.Y.,Franks S., Reed M.J. Effect of insulin-like growth factor type 1 and insulin on
the secretion of sex hormone binding globulin and IGF1 binding protein 1 by
1-R3.
107. Spellacy W.N. Carbohydrate metabolism during treatment with estrogen,progestogen, and low-dose oral contraceptive. Am. J. Obstet. Gynecol., 1982,
142, 732-734.
108. Staland B. Continuous treatment with a combination of estrogen andgestoden away of avoiding endometrial stimulation. Acta Obstet. Gynecol.
Scand., 1985, Suppl. 130, 29-35.
109. Stein I.F., Hamilton-Fairley D. Amenorrhea associated with bilateralpolycystic ovaries. Am. J. Obstet. Gynecol., 1935, 29, 181-191.
110. Steinberg K.K., Fremi-Titulaer L.W., Depuey E.G., Miller D.T., SgontasD.S., Coralli C.H., Phillips D.L., Rogers T.N., Clark R.V. Sex steroids and
bone density in premenopausal and perimenopausal women. J. Clin. Endocrinol.
Metab., 1989, 69, 533-539.
111. Stoll B.A. Breast cancer: the obesity connection. Br. J. Cancer, 1994, 69,799-801.
112. Stones R.W., Paterson C.M., Saunders N.J. Risk factors for major obstetrichæmorrhage. Eur. J. Obstet. Gynecol. Reprod. Biol., 1993, 48, 15-18.
113. Su T.H., Wang K.G., Yang Y.C., Hong B.K., Huang S.H. Laparoscopicpara-aortic lymph node sampling in the staging of invasive cervical carcinoma:
including a comparative study of 21 laparotomy cases. Int. J. Gynecol. Obstet.,
1995, 49, 311-318.
114. Swanson C.A., Potischman N., Barret R.J., Berman M.L, Mortel R., TwiggsL.B. , Willbanks G.D., Hoover R.N., Brinton L.A. Endometrial cancer risk in
relation to serum lipid and lipoprotein levels. Cancer Epidemiology Biomarkers
and Prevention, 1994, 3, 575-581.
115. Swanson C.A., Potischman N., Wilbanks G.D., Twiggs L.B., Mortel R., BermanM.L., Barret R.J., Baumgartner R.N., Brinton L.A. Relation of endometrial
cancer risk to past and contemporary body size and body fat distribution.
Cancer Epidemiology Biomarkers and Prevention, 1993; 2; 321-327.
116. Talwar P.P., Berger G.S. The relation of body weight to side effectsassociated with oral contraceptives. Lancet, 1977, i, 1637-1638.
117. The writing group for the PEPI trial. Effects of oestrogen oroestrogen/progestin regimens on heart disease risk factors in postmenopausal
women. JAMA, 1995, 273, 199-208.
118. Törnberg S.A , Carstensen J.M. Relationship between Quetelet indexand cancer of breast and female genital tract in 47000 womens followed 25
years. Br. J. Cancer, 1994, 69, 358-361.
119. Trémollières F.A., Puoilles J.M., Ribot C.L. Vertebralpostmenopausal bone loss is reduced in overweight women: a longitudinal study
in 155 early postmenopausal women. J. Clin. Endocrinol. Metab., 1993, 77, 683-
686.
120. Vague J. Influence des hormones sur la régulationmétabolique du tissu adipeux et sa répartition. Reprod. Hum.
Horm., 1993, 6, 299-304.
121. Vague J., Meignen J.M., Negrin J.F., Thomas M., Tramoni M., Jubelin J.Androgènes, estrogènes et cortisol dans la physiopathologie du
tissu adipeux. Sem. Hôp., 1984, 60, 1389-93 et 1465-76.
122. Vague J., Vague Ph., Jubelin J. Barre A. Fat distribution, obesities andhealth: evolution of concepts. Bouchards C., Johnston F.E. Fat distribution
during growth and later health outcomes, Liss A-R Inc., 1988, New-York, 9-41.
123. Wallace D.H., Cunie J.M., Gilstrap L.C., Santos R. Indirect sonographicguidance for epidural anesthesia in obese pregnant patients. Regional
Anesthesia, 1992, 17, 233-236.
124. Waller D.K., Mills J.L., Simpson J.L., Cunningham G.C., Conley M.R.,Lassman M.R., Rhoads C.C. Are obese women at higher risk for producing
malformed offspring? Am. J. Obstet. Gynecol, 1994, 170, 541-598.
125. Wiel-Masson D., Bedda S. Variations pondérales en péri etpost-ménopause. Reprod. Hum. Horm., 1993, 6, 325-336.
126. Wilcox A., Weinberg C., Baird D. Caffeinated beverages and decreasedfertility. Lancet, 1988, 2, 1453-1455.
127. Wing R.R., Matthews K.A., Kuller L.H., Meilahn E.N., Plantinga P.M. Weightgain at the time of menopause. Arch. Inter. Med, 1991, 151, 97-102.
128. Wolfe H.M., Gross T.L. Obesity in Pregnancy Clin. Obstet. Gynecol., 1994,37, 596-604.
37-S40.
247-S251.